13D/13G Filings - Viridian Therapeutics Inc.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-14
4:06 pm
Purchase
2022-12-31 13G Viridian Therapeutics, Inc.
VRDN
Commodore Capital LP 2,020,166
5.000%
2,020,166increase
(New Position)
Filing
History
2023-02-14
12:19 pm
Sale
2022-12-31 13G Viridian Therapeutics, Inc.
VRDN
Avidity Partners Management LP 0
0.000%
-1,278,261decrease
(Position Closed)
Filing
History
2022-02-11
8:10 pm
Purchase
2021-12-31 13G Viridian Therapeutics, Inc.
VRDN
Avidity Partners Management LP 1,278,261
5.900%
1,278,261increase
(New Position)
Filing
History